These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 17160771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct 16; 150(42):52-3. PubMed ID: 18983063
    [No Abstract] [Full Text] [Related]

  • 3. [New guidelines in acute coronary syndrome. Clopidogrel for nine months is recommended].
    MMW Fortschr Med; 2002 Oct 03; 144(40):47. PubMed ID: 12440296
    [No Abstract] [Full Text] [Related]

  • 4. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
    MMW Fortschr Med; 2003 Jul 10; 145(27-28):64. PubMed ID: 14587200
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The year in non-ST-segment elevation acute coronary syndromes.
    Giugliano RP, Braunwald E.
    J Am Coll Cardiol; 2006 Jul 18; 48(2):386-95. PubMed ID: 16843191
    [No Abstract] [Full Text] [Related]

  • 9. [After coronary intervention. Which platelet inhibitor for whom?].
    Stiefelhagen P.
    MMW Fortschr Med; 2007 Apr 05; 149(14):18-9. PubMed ID: 17668756
    [No Abstract] [Full Text] [Related]

  • 10. Dosing of clopidogrel and aspirin in acute coronary syndromes.
    Merella P, Casu G, Meloni I.
    N Engl J Med; 2010 Dec 16; 363(25):2466-7; author reply 2467-8. PubMed ID: 21158665
    [No Abstract] [Full Text] [Related]

  • 11. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
    Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E, PRINCIPLE-TIMI 44 Investigators.
    Circulation; 2007 Dec 18; 116(25):2923-32. PubMed ID: 18056526
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clopidogrel in acute coronary syndromes.
    Chua D, Ignaszewski A.
    BMJ; 2009 Apr 14; 338():b1180. PubMed ID: 19366756
    [No Abstract] [Full Text] [Related]

  • 15. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
    Di Nisio M, Bijsterveld NR, Meijers JC, Levi M, Büller HR, Peters RJ.
    J Am Coll Cardiol; 2005 Oct 18; 46(8):1582-3. PubMed ID: 16226189
    [No Abstract] [Full Text] [Related]

  • 16. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct 18; 18(103):193-5. PubMed ID: 19877380
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Fefer P, Hod H, Hammerman H, Segev A, Beinart R, Boyko V, Behar S, Matetzky S.
    Am J Cardiol; 2009 Aug 15; 104(4):514-8. PubMed ID: 19660604
    [Abstract] [Full Text] [Related]

  • 18. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
    O'Donoghue M, Wiviott SD.
    Circulation; 2006 Nov 28; 114(22):e600-6. PubMed ID: 17130347
    [No Abstract] [Full Text] [Related]

  • 19. The loading dose of clopidogrel in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty.
    Lin GM, Han CL.
    Am J Emerg Med; 2010 Mar 28; 28(3):382-3. PubMed ID: 20223400
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD.
    J Am Coll Cardiol; 2009 Aug 18; 54(8):678-85. PubMed ID: 19679245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.